Kolexia
Thiebaut Anne Hématologie
Thiebaut Anne
Hématologie
Hôpital Nord Grenoble
La Tronche, France
147 Activités
803 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Leucémies Aspergillose Leucémie-lymphome lymphoblastique à précurseurs B et T Tumeurs hématologiques Leucémie aigüe myéloïde Mycoses Infections à cytomégalovirus COVID-19 Leucémie myéloïde

Collaborateurs

Voir plus
Chevallier Patrice
Chevallier Patrice
Hôpital Hôtel-Dieu Nantes, Nantes, France
Bulabois Claude
Bulabois Claude
Hôpital Nord Grenoble, La Tronche, France
Cahn Jean-Yves
Cahn Jean-Yves
Hôpital Nord Grenoble, La Tronche, France
Huynh-Finkeltin Anne
Huynh-Finkeltin Anne
Institut Universitaire du Cancer Toulouse Oncopole, Toulouse, France

Industries

Voir plus
Gilead
15 collaboration(s)
Dernière en 2023
Pfizer
10 collaboration(s)
Dernière en 2023
MSD
6 collaboration(s)
Dernière en 2023
Takeda Pharmaceutical
4 collaboration(s)
Dernière en 2021

Dernières activités

Voir plus
Nilotinib with or without cytarabine for Philadelphia positive acute lymphoblastic leukemia.
Blood   07 mars 2024
Early picc-line infections in non-neutropenic patients are mainly due to E. coli suggesting that third-generation cephalosporin may be used as a first-line antibiotic therapy.
Infectious diseases now   29 novembre 2023
Pneumocystis pneumonia after allogeneic hematopoietic cell transplantation: A case-control study on epidemiology and risk factors on behalf of the Infectious Diseases Working Party of the European Society for Blood and Marrow Transplantation.
Transplantation and cellular therapy   23 novembre 2023
Involvement of the JAK-STAT Pathway in the Molecular Landscape of Fusion-Free Myeloid Neoplasms with Eosinophilia
65th ASH Annual Meeting Abstracts   02 novembre 2023
Efficacy and Tolerance of Brexucabtagene Autoleucel in Adults with Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia : A Graall Study from the Descar-T Registry
65th ASH Annual Meeting Abstracts   02 novembre 2023
A Phase 2 Study of Ponatinib for Prevention of Relapse after Allotransplantation in FLT3-ITD + AML Patients : The Ponallo Trial
65th ASH Annual Meeting Abstracts   02 novembre 2023
Exploring the Heterogeneity of Response to Blinatumomab in High-Risk Philadelphia-Negative B-Cell Precursor Acute Lymphoblastic Leukemia: An Analysis from the QUEST Sub-Study of the Graall-2014/B Trial
65th ASH Annual Meeting Abstracts   02 novembre 2023
Genetic alterations and MRD refine risk assessment within KMT2A-rearranged B-cell precursor ALL in adult: a GRAALL study.
Blood   18 août 2023
Comment on 'Therapeutic drug monitoring-guided treatment versus standard dosing of voriconazole for invasive aspergillosis in haematological patients: A multicentre, prospective, cluster randomised, crossover clinical trial'.
International journal of antimicrobial agents   18 mai 2023
MTSA: A Phase II, Multicenter, Open Label Study Evaluating the Efficacy and the Tolerance of Micro-transplantation in Elderly Patients With Acute Myeloid Leukemia (MTSA)
Essai Clinique (CHU Saint-Étienne)   04 mai 2023